StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
227
This month
2
This year
8
Publishing Date
2023 - 10 - 31
2
2023 - 10 - 18
2
2023 - 09 - 08
2
2023 - 08 - 08
2
2023 - 06 - 15
2
2023 - 05 - 09
2
2023 - 04 - 04
2
2022 - 12 - 16
4
2022 - 11 - 01
2
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 04 - 18
2
2022 - 02 - 14
2
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 11 - 26
2
2021 - 11 - 20
2
2021 - 11 - 17
2
2021 - 11 - 01
2
2021 - 09 - 23
2
2021 - 08 - 05
2
2021 - 06 - 17
2
2021 - 06 - 11
2
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 06 - 07
1
2021 - 06 - 04
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 10
1
2021 - 05 - 05
1
2021 - 05 - 03
1
2021 - 04 - 23
2
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 04 - 05
1
2021 - 03 - 15
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 16
2
2021 - 02 - 04
3
2021 - 02 - 02
2
2021 - 01 - 28
1
2021 - 01 - 22
2
2021 - 01 - 15
1
2021 - 01 - 07
1
2021 - 01 - 06
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 17
2
2020 - 12 - 09
1
Sector
Consumer durables
1
Consumer services
1
Distribution services
1
Electronic technology
1
Energy minerals
1
Finance
1
Health care and social assistance
1
Health technology
227
Manufacturing
2
N/a
2
Non-energy minerals
1
Process industries
2
Producer manufacturing
1
Retail trade
1
Technology services
3
Utilities
1
Tags
Agreement
2
Alliances
3
Antibody
3
Application
4
Approval
10
Approved
4
Australia
4
Authorization
24
Authorized
5
Awards
3
Biocapital
29
Biopharma
3
Bioscience
2
Biotech
2
Biotechnology
22
Canada
3
Candidate
2
Chmp
3
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
4
Conference
26
Congress
2
Covid
67
Covid-19
93
Deadline
5
Disease
7
Earnings
6
Emergency use authorization
10
Europe
9
Events
9
Fda
11
Financial
10
Financial results
7
Global
3
Grant
5
Granted
8
Grants
3
Health
7
India
10
Influenza
7
License
3
Merge
9
N/a
131
Nuvaxovid
3
Nvx-cov2373
5
Offering
6
People
4
Phase 2
5
Phase 2b
3
Phase 3
13
Positive
6
Product-news
3
Prototype
5
Research
10
Results
27
Submission
5
Switzerland
3
Trial
20
Vaccine
132
World
3
Entities
Abbott laboratories
1
Alector, inc.
1
Arcturus therapeutics holdings inc.
1
Ardelyx, inc.
1
Arrival
1
Astellas pharma inc
1
Astrazeneca plc
4
Baxter international inc.
1
Biogen inc.
2
Biontech se
3
Bristol-myers squibb company
1
Cidara therapeutics, inc.
1
Codexis, inc.
1
Emergent biosolutions, inc.
1
Endo international plc
1
Glaxosmithkline plc
4
Henry schein, inc.
1
Icosavax inc
1
Immunocellular therapeutics, ltd.
1
Inovio pharmaceuticals, inc.
1
Johnson & johnson
16
Legend biotech corporation
1
Lordstown motors corp.
1
Mks instruments, inc.
1
Moderna, inc.
9
Modivcare inc
1
Morgan stanley
1
Msci inc
1
Mueller industries, inc.
1
Netflix, inc.
1
Neurocrine biosciences, inc.
1
Newmont corporation
1
Nkarta, inc.
1
Novartis ag
1
Novavax, inc.
227
Nrg energy, inc.
1
Nutanix, inc.
1
Nutrien ltd.
1
Oge energy corp
1
Olympic steel, inc.
1
Omnicell, inc.
1
Ovintiv inc.
1
Par pacific holdings, inc.
1
Paycom software, inc.
1
Paypal holdings, inc.
1
Penumbra, inc.
1
Pfizer, inc.
2
Pinterest, inc.
1
Qualcomm incorporated
1
Rayonier advanced materials inc.
1
Regeneron pharmaceuticals, inc.
1
Relmada therapeutics, inc.
1
Renewable energy group, inc.
1
Renovacor, inc.
2
Sanofi
18
Snap inc.
1
Soligenix, inc.
1
Stoneco ltd.
1
Takeda pharmaceutical company limited
4
Walmart inc.
1
Symbols
A
429
ABBV
1023
ABT
1784
ALPMF
332
ALPMY
332
AMGN
742
AZN
664
AZNCF
447
BAX
483
BDX
796
BGNE
323
BHC
389
BIIB
381
BIO
448
BMY
662
BNTX
366
BSX
575
BWAY
330
DHR
785
FNCTF
489
GILD
499
GLAXF
657
GMAB
297
GOOG
300
GOOGL
301
GSK
883
HEPA
403
HOLX
328
ILMN
451
INCY
444
JNJ
4571
LLY
1708
MDT
1285
MOR
313
MPSYF
269
MRK
336
MRNA
349
MS
619
NKTR
365
NVO
631
NVS
1241
NVSEF
1031
OCX
481
PFE
692
PHG
962
PKI
274
PRVB
348
QGEN
369
REGN
419
RYLPF
438
SNY
4532
SNYNF
3590
STRO
270
SYK
536
TAK
419
TEVJF
630
TMO
1621
TXMD
277
VTRS
364
VXRT
313
Exchanges
Nasdaq
227
Nyse
23
Crawled Date
2023 - 10 - 31
2
2023 - 10 - 18
2
2023 - 09 - 08
2
2023 - 08 - 08
2
2023 - 06 - 15
2
2023 - 05 - 09
2
2023 - 04 - 04
2
2022 - 12 - 16
4
2022 - 11 - 01
2
2022 - 09 - 16
2
2022 - 09 - 13
2
2022 - 07 - 26
2
2022 - 07 - 19
2
2022 - 04 - 18
2
2022 - 02 - 14
2
2022 - 02 - 11
2
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 11 - 26
2
2021 - 11 - 17
2
2021 - 11 - 01
2
2021 - 09 - 23
2
2021 - 08 - 05
2
2021 - 06 - 11
2
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 06 - 07
1
2021 - 06 - 05
1
2021 - 05 - 27
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 10
1
2021 - 05 - 06
1
2021 - 05 - 03
1
2021 - 04 - 24
1
2021 - 04 - 23
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 04 - 05
1
2021 - 03 - 15
1
2021 - 03 - 08
1
2021 - 03 - 01
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 16
2
2021 - 02 - 04
3
2021 - 02 - 02
2
2021 - 01 - 28
1
2021 - 01 - 22
2
2021 - 01 - 15
1
2021 - 01 - 08
1
2021 - 01 - 06
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 17
2
2020 - 12 - 09
1
Crawled Time
00:00
3
00:20
4
01:00
7
02:00
2
03:00
2
04:20
2
05:00
4
06:00
2
07:00
1
08:00
2
10:00
2
11:00
7
12:00
13
12:03
1
12:15
1
12:20
6
12:30
1
12:57
1
13:00
18
13:03
3
13:15
3
13:20
5
13:30
2
14:00
21
14:03
1
14:15
1
14:20
3
14:30
6
15:00
12
15:20
3
15:30
2
16:00
8
16:20
2
17:00
5
18:00
7
19:00
10
20:00
6
21:00
14
21:03
2
22:00
15
22:01
2
23:00
14
23:01
1
Source
www.biospace.com
96
www.fda.gov
1
www.globenewswire.com
20
www.prnewswire.com
110
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
NVAX
save search
Labaton Keller Sucharow LLP Announces Proposed Settlement on Behalf of Purchasers of Lordstown Motors Corp. Securities - RIDE RIDEW
Published:
2024-04-05
(Crawled : 13:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-15.62%
|
O:
-4.77%
H:
3.3%
C:
0.68%
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Published:
2024-04-01
(Crawled : 12:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-20.12%
|
O:
-1.03%
H:
0.62%
C:
-3.53%
covid-19
candidate
vaccine
congress
world
Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP Announce Notice of Pendency of Stockholder Class Actions and Proposed Settlement for All Record and Beneficial Owners of Pattern Energy Group Inc. Common Stock as of March 16, 2020
Published:
2024-03-18
(Crawled : 14:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-26.47%
|
O:
-0.95%
H:
2.48%
C:
-1.91%
energy
group
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
Published:
2024-02-29
(Crawled : 21:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-21.26%
|
O:
3.04%
H:
8.06%
C:
5.89%
conference
health
care
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published:
2024-02-28
(Crawled : 15:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-35.38%
|
O:
-22.92%
H:
1.29%
C:
-4.96%
year
financial
results
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Published:
2024-02-22
(Crawled : 11:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-2.26%
|
O:
12.06%
H:
22.42%
C:
9.42%
covid-19
vaccine
reach
agreement
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
Published:
2024-02-20
(Crawled : 15:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-6.49%
|
O:
0.0%
H:
1.68%
C:
-0.72%
conference
year
financial
results
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-03
(Crawled : 15:30)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-22.66%
|
O:
-0.6%
H:
0.0%
C:
-2.2%
conference
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
Published:
2023-12-05
(Crawled : 21:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-30.41%
|
O:
0.18%
H:
3.93%
C:
-0.36%
covid-19
authorized
vaccine
canada
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
Published:
2023-11-28
(Crawled : 11:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-28.75%
|
O:
1.1%
H:
5.07%
C:
3.8%
covid-19
vaccine
health
world
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Published:
2023-11-17
(Crawled : 12:30)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-33.28%
|
O:
-0.17%
H:
2.41%
C:
-1.55%
HSIC
|
$70.21
-1.42%
-1.44%
1.1M
|
Distribution Services
|
2.09%
|
O:
0.57%
H:
0.4%
C:
-0.58%
Novavax to Participate in Jefferies London Healthcare Conference
Published:
2023-11-10
(Crawled : 14:30)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-42.03%
|
O:
-0.45%
H:
0.15%
C:
-6.59%
conference
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
Published:
2023-11-09
(Crawled : 14:30)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-42.79%
|
O:
1.91%
H:
8.08%
C:
-3.17%
financial
results
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
Published:
2023-11-02
(Crawled : 15:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-44.43%
|
O:
-0.71%
H:
3.88%
C:
2.73%
conference
financial
results
Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published:
2023-10-31
(Crawled : 21:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-41.59%
|
O:
0.6%
H:
5.22%
C:
4.48%
covid-19
vaccine
approved
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
Published:
2023-10-31
(Crawled : 17:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-40.34%
|
O:
-0.46%
H:
5.24%
C:
2.62%
covid-19
chmp
vaccine
positive
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published:
2023-10-18
(Crawled : 13:30)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-39.69%
|
O:
-0.78%
H:
2.5%
C:
1.09%
covid-19
vaccine
prototype
approval
Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom
Published:
2023-10-18
(Crawled : 12:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-39.69%
|
O:
-0.78%
H:
2.5%
C:
1.09%
covid-19
vaccine
prototype
authorization
Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S.
Published:
2023-10-13
(Crawled : 13:30)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-47.79%
|
O:
-0.67%
H:
0.0%
C:
-4.73%
covid-19
vaccine
retail
Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
Published:
2023-10-11
(Crawled : 14:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-47.29%
|
O:
0.68%
H:
9.29%
C:
2.69%
europe
vaccine
congress
world
technology
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.